A consistent correlation between PSA and methylation patterns was noted in the majority of patients; however, we wish to highlight one case in particular: A 76-year-old male patient underwent docetaxel treatment subsequent to the progression of metastatic disease involving osseous and lymphogenous sites while on enzalutamide. The gene discussed is KLK3; the disease is metastatic neoplasm.